Market Closed -
Other stock markets
|
Pre-market 09:29:09 am | |||
7.81 USD | -14.64% | 8.435 | +8.00% |
Financials (USD)
Sales 2024 * | 71.56M | Sales 2025 * | 277M | Capitalization | 5.29B |
---|---|---|---|---|---|
Net income 2024 * | -437M | Net income 2025 * | -307M | EV / Sales 2024 * | 73.9 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 19.1 x |
P/E ratio 2024 * |
-10.5
x | P/E ratio 2025 * |
-15
x | Employees | 628 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 20.69% |
Latest transcript on ImmunityBio, Inc.
1 week | -13.13% | ||
Current month | -2.25% | ||
1 month | +36.78% | ||
3 months | +85.07% | ||
6 months | +116.94% | ||
Current year | +55.58% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Adcock
CEO | Chief Executive Officer | 55 | 20-09-30 |
Founder | 71 | 14-11-30 | |
David Sachs
DFI | Director of Finance/CFO | 46 | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 71 | 14-11-30 | |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 19-05-31 |
Wesley Clark
BRD | Director/Board Member | 78 | 21-02-23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.02% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 7.81 | -14.64% | 10,789,460 |
24-05-03 | 9.15 | +2.01% | 14,704,253 |
24-05-02 | 8.97 | +5.04% | 9,810,042 |
24-05-01 | 8.54 | +6.88% | 12,801,089 |
24-04-30 | 7.99 | -11.12% | 15,004,108 |
Delayed Quote Nasdaq, May 06, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.58% | 5.29B | |
+9.15% | 106B | |
-1.08% | 104B | |
+5.79% | 23.25B | |
-11.55% | 22.5B | |
-7.01% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B |
- Stock Market
- Equities
- IBRX Stock